Alstrom syndrome medical therapy: Difference between revisions

Jump to navigation Jump to search
Raviteja Reddy Guddeti (talk | contribs)
No edit summary
Raviteja Reddy Guddeti (talk | contribs)
Line 14: Line 14:


===Insulin Resistance/Type 2 Diabetes===
===Insulin Resistance/Type 2 Diabetes===
Should be treated as in the general population unless [[heart failure]] and/or liver dysfunction are present. The [[diabetes mellitus]] is characterized by insulin resistance, but some individuals respond to a low-sugar, low-fat diet; exercise; and [[metformin]]. [[Glitazone]]s are added to further reduce [[insulin]] resistance but must be avoided in the presence of active or treated heart failure. These treatments should be discontinued when the [[serum creatinine]] concentration exceeds 200 µmol/L or if [[cardiomyopathy]] is evident. [[Incretin]] analogues given subcutaneously, as in nonsyndromic [[type 2 diabetes]], are successful in two thirds of cases.
Should be treated as in the general population unless [[heart failure]] and/or liver dysfunction are present. The [[diabetes mellitus]] is characterized by insulin resistance, but some individuals respond to a low-sugar, low-fat diet; exercise; and [[metformin]]. [[Glitazones]] are added to further reduce [[insulin]] resistance but must be avoided in the presence of active or treated heart failure. These treatments should be discontinued when the [[serum creatinine]] concentration exceeds 200 µmol/L or if [[cardiomyopathy]] is evident. [[Incretin]] analogues given subcutaneously, as in nonsyndromic [[type 2 diabetes]], are successful in two thirds of cases.


===Hypertriglyceridemia===
===Hypertriglyceridemia===

Revision as of 15:15, 25 February 2013

Alstrom syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Differentiating Alstrom syndrome from other Diseases

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alstrom syndrome medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Alstrom syndrome medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alstrom syndrome medical therapy

CDC on Alstrom syndrome medical therapy

Alstrom syndrome medical therapy in the news

Blogs on Alstrom syndrome medical therapy

Directions to Hospitals Treating Alstrom syndrome

Risk calculators and risk factors for Alstrom syndrome medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]

Medical Therapy

Rod-Cone Dystrophy

Use of red-orange tinted prescription lenses may reduce symptoms early in the disease phase when photodysphoria is significant. Instruction in the use of Braille, mobility training, adaptive living skills, and computing skills (including voice recognition and transcription software), and the use of large print reading materials while vision is still present are crucial.

Obesity

Regular exercise and a healthy low calorie diet are recommended for weight control.

Cardiomyopathy

Angiotensinogen-converting enzyme (ACE) inhibitors, diuretics, digoxin, and possibly beta-blockers should be used in the treatment of cardiac failure.

Insulin Resistance/Type 2 Diabetes

Should be treated as in the general population unless heart failure and/or liver dysfunction are present. The diabetes mellitus is characterized by insulin resistance, but some individuals respond to a low-sugar, low-fat diet; exercise; and metformin. Glitazones are added to further reduce insulin resistance but must be avoided in the presence of active or treated heart failure. These treatments should be discontinued when the serum creatinine concentration exceeds 200 µmol/L or if cardiomyopathy is evident. Incretin analogues given subcutaneously, as in nonsyndromic type 2 diabetes, are successful in two thirds of cases.

Hypertriglyceridemia

Nicotinic acid derivatives can be helpful in long-term reduction of severe hypertriglyceridemia (>20 mmol/l) especially if pancreatitis has occurred and diabetes is absent or well controlled. Statins are unlikely to be effective but can be considered for long-term prevention of atherosclerosis in adults with low HDL, high LDL, and diabetes. Pancreatitis should be treated as in the general population.

Endocrine Disorders

  • Gonadotropin and pituitary hormones should be assessed to determine if hormonal adjustments are necessary when the child approaches puberty.
  • Testosterone is used to treat male hypogonadism to preserve sexuality, muscle strength, and bone health.
  • Hypothyroidism is treated by thyroxine therapy.

Renal Failure

If proteinuria is detected, use of enzyme ACE inhibitors may be considered.

Hepatic Dysfunction

Portal hypertension can be treated using beta-blockade and sclerotherapy of the esophageal veins. Banding should be done in order to prevent upper-GI hemorrhage from varices.

Pulmonary Disease

General activity, including breathing exercises, can reduce chronic hypoxia and improve well being. Coaching by an exercise expert may be necessary in order to achieve adequate spirometry results to determine the presence of obstructive airways disease.

References

Template:WikiDoc Sources